SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form N-CSR - Certified Shareholder Report:
SEC Accession No. 0001193125-23-044824
Filing Date
2023-02-22
Accepted
2023-02-22 16:11:07
Documents
4
Period of Report
2022-12-31
Effectiveness Date
2023-02-22

Document Format Files

Seq Description Document Type Size
1 HEALTH SCIENCES FUND_HSF_F114-050 d403076dncsr.htm N-CSR 3589023
2 302 CERTIFICATIONS d403076dex99cert.htm EX-99.CERT 22581
3 906 CERTIFICATIONS d403076dex99906ce.htm EX-99.906CE 4640
4 CODE OF ETHICS d403076dex99codeeth.htm EX-99.CODE ETH 26875
  Complete submission text file 0001193125-23-044824.txt   3644907

Series and Classes/Contracts Information:

Existing
  Status Name Ticker Symbol
CIK 0001002624      
Series S000002088   T. Rowe Price Health Sciences Fund, Inc.
Class/Contract C000005456   T. Rowe Price Health Sciences Fund, Inc. PRHSX
Class/Contract C000169937   T. Rowe Price Health Sciences Fund-I Class THISX
Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202
Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 410-345-2000
T. Rowe Price Health Sciences Fund, Inc. (Filer) CIK: 0001002624 (see all company filings)

IRS No.: 521952906 | State of Incorp.: MD | Fiscal Year End: 1231
Type: N-CSR | Act: 40 | File No.: 811-07381 | Film No.: 23653211